| Year |
Citation |
Score |
| 2019 |
Potashkin JA, Bottero V, Santiago JA, Quinn JP. Computational identification of key genes that may regulate gene expression reprogramming in Alzheimer's patients. Plos One. 14: e0222921. PMID 31545826 DOI: 10.1371/journal.pone.0222921 |
0.361 |
|
| 2019 |
Potashkin J, Huang X, Becker C, Chen H, Foltynie T, Marras C. Understanding the links between cardiovascular disease and Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 31483535 DOI: 10.1002/Mds.27836 |
0.661 |
|
| 2018 |
Chen-Plotkin AS, Albin R, Alcalay R, Babcock D, Bajaj V, Bowman D, Buko A, Cedarbaum J, Chelsky D, Cookson MR, Dawson TM, Dewey R, Foroud T, Frasier M, German D, ... ... Potashkin J, et al. Finding useful biomarkers for Parkinson's disease. Science Translational Medicine. 10. PMID 30111645 DOI: 10.1126/Scitranslmed.Aam6003 |
0.503 |
|
| 2018 |
Santiago JA, Bottero V, Potashkin JA. Evaluation of RNA Blood Biomarkers in the Parkinson's Disease Biomarkers Program. Frontiers in Aging Neuroscience. 10: 157. PMID 29896099 DOI: 10.3389/fnagi.2018.00157 |
0.485 |
|
| 2017 |
Santiago JA, Bottero V, Potashkin JA. Biological and Clinical Implications of Comorbidities in Parkinson's Disease. Frontiers in Aging Neuroscience. 9: 394. PMID 29255414 DOI: 10.3389/fnagi.2017.00394 |
0.645 |
|
| 2017 |
Gwinn K, David KK, Swanson-Fischer C, Albin R, Hillaire-Clarke CS, Sieber BA, Lungu C, Bowman FD, Alcalay RN, Babcock D, Dawson TM, Dewey RB, Foroud T, German D, Huang X, ... ... Potashkin JA, et al. Parkinson's disease biomarkers: perspective from the NINDS Parkinson's Disease Biomarkers Program. Biomarkers in Medicine. PMID 28644039 DOI: 10.2217/Bmm-2016-0370 |
0.582 |
|
| 2017 |
Santiago JA, Bottero V, Potashkin JA. Dissecting the Molecular Mechanisms of Neurodegenerative Diseases through Network Biology. Frontiers in Aging Neuroscience. 9: 166. PMID 28611656 DOI: 10.3389/fnagi.2017.00166 |
0.398 |
|
| 2017 |
Santiago JA, Potashkin JA. Blood Transcriptomic Meta-analysis Identifies Dysregulation of Hemoglobin and Iron Metabolism in Parkinson' Disease. Frontiers in Aging Neuroscience. 9: 73. PMID 28424608 DOI: 10.3389/fnagi.2017.00073 |
0.373 |
|
| 2016 |
Santiago JA, Littlefield AM, Potashkin JA. Integrative transcriptomic meta-analysis of Parkinson's disease and depression identifies NAMPT as a potential blood biomarker for de novo Parkinson's disease. Scientific Reports. 6: 34579. PMID 27680512 DOI: 10.1038/srep34579 |
0.563 |
|
| 2015 |
Santiago JA, Potashkin JA. Blood Biomarkers Associated with Cognitive Decline in Early Stage and Drug-Naive Parkinson's Disease Patients. Plos One. 10: e0142582. PMID 26566043 DOI: 10.1371/journal.pone.0142582 |
0.54 |
|
| 2015 |
Santiago JA, Potashkin JA. Reply to Toker and Pavlidis: Blood biomarkers for Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America. 112: E3638. PMID 26106166 DOI: 10.1073/pnas.1508415112 |
0.474 |
|
| 2015 |
Santiago JA, Potashkin JA. Network-based metaanalysis identifies HNF4A and PTBP1 as longitudinally dynamic biomarkers for Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America. 112: 2257-62. PMID 25646437 DOI: 10.1073/pnas.1423573112 |
0.6 |
|
| 2014 |
Santiago JA, Potashkin JA. Current Challenges Towards the Development of a Blood Test for Parkinson's Disease. Diagnostics (Basel, Switzerland). 4: 153-64. PMID 26852683 DOI: 10.3390/diagnostics4040153 |
0.621 |
|
| 2014 |
Santiago JA, Potashkin JA. A network approach to clinical intervention in neurodegenerative diseases. Trends in Molecular Medicine. 20: 694-703. PMID 25455073 DOI: 10.1016/j.molmed.2014.10.002 |
0.378 |
|
| 2014 |
Santiago JA, Scherzer CR, Potashkin JA. Network analysis identifies SOD2 mRNA as a potential biomarker for Parkinson's disease. Plos One. 9: e109042. PMID 25279756 DOI: 10.1371/journal.pone.0109042 |
0.546 |
|
| 2014 |
Santiago JA, Potashkin JA. System-based approaches to decode the molecular links in Parkinson's disease and diabetes. Neurobiology of Disease. 72: 84-91. PMID 24718034 DOI: 10.1016/j.nbd.2014.03.019 |
0.588 |
|
| 2014 |
Seidl SE, Santiago JA, Bilyk H, Potashkin JA. The emerging role of nutrition in Parkinson's disease. Frontiers in Aging Neuroscience. 6: 36. PMID 24639650 DOI: 10.3389/fnagi.2014.00036 |
0.641 |
|
| 2014 |
Santiago JA, Potashkin JA. A network approach to diagnostic biomarkers in progressive supranuclear palsy. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 550-5. PMID 24347522 DOI: 10.1002/mds.25761 |
0.45 |
|
| 2013 |
Santiago JA, Potashkin JA. Integrative network analysis unveils convergent molecular pathways in Parkinson's disease and diabetes. Plos One. 8: e83940. PMID 24376773 DOI: 10.1371/journal.pone.0083940 |
0.378 |
|
| 2013 |
Santiago JA, Scherzer CR, Potashkin JA, Hyman BT, Ivinson AJ, Trisini-Lipsanopoulos A, Dhima K, Bayer S, Lockhart KC, Yi T, Liao Z, Hoesing AN, Duong K, Roderick S, Sudarsky LR, et al. Specific splice variants are associated with Parkinson's disease Movement Disorders. 28: 1724-1727. PMID 24108702 DOI: 10.1002/mds.25635 |
0.552 |
|
| 2013 |
Santiago JA, Potashkin JA. Shared dysregulated pathways lead to Parkinson's disease and diabetes. Trends in Molecular Medicine. 19: 176-86. PMID 23375873 DOI: 10.1016/j.molmed.2013.01.002 |
0.416 |
|
| 2013 |
Seidl SE, Potashkin JA. Erratum: The promise of neuroprotective agents in Parkinson's disease Frontiers in Neuroscience. 7. DOI: 10.3389/fnins.2013.00069 |
0.627 |
|
| 2012 |
Potashkin JA, Santiago JA, Ravina BM, Watts A, Leontovich AA. Biosignatures for Parkinson's disease and atypical parkinsonian disorders patients. Plos One. 7: e43595. PMID 22952715 DOI: 10.1371/journal.pone.0043595 |
0.564 |
|
| 2011 |
Seidl SE, Potashkin JA. The promise of neuroprotective agents in Parkinson's disease. Frontiers in Neurology. 2: 68. PMID 22125548 DOI: 10.3389/fneur.2011.00068 |
0.644 |
|
| 2010 |
Potashkin JA, Blume SR, Runkle NK. Limitations of animal models of Parkinson's disease. Parkinson's Disease. 2011: 658083. PMID 21209719 DOI: 10.4061/2011/658083 |
0.607 |
|
| 2008 |
Meredith GE, Totterdell S, Potashkin JA, Surmeier DJ. Modeling PD pathogenesis in mice: advantages of a chronic MPTP protocol. Parkinsonism & Related Disorders. 14: S112-5. PMID 18585085 DOI: 10.1016/j.parkreldis.2008.04.012 |
0.528 |
|
| 2007 |
Potashkin JA, Kang UJ, Loomis PA, Jodelka FM, Ding Y, Meredith GE. MPTP administration in mice changes the ratio of splice isoforms of fosB and rgs9. Brain Research. 1182: 1-10. PMID 17936734 DOI: 10.1016/J.Brainres.2007.08.080 |
0.348 |
|
| 2007 |
Marinescu V, Loomis PA, Ehmann S, Beales M, Potashkin JA. Regulation of retention of FosB intron 4 by PTB. Plos One. 2: e828. PMID 17786200 DOI: 10.1371/Journal.Pone.0000828 |
0.408 |
|
| Show low-probability matches. |